Globally Relevant
Evidence.
Rigorously Generated.
Globally Relevant Evidence.
Rigorously Generated.
Globally Relevant Evidence.
Rigorously Generated.
Globally Relevant Evidence. Rigorously Generated.
Each study we execute is designed around real-world outcomes, validated endpoints and sponsor objectives. Our experience spans study strategy, execution and publication—ensuring results that matter. A walk-through our past studies experience that helps brands move beyond data—toward differentiation, trust and growth.
Get in Touch
How Vedic supported an FDA 505(b)(2) pathway by bridging a novel amoxicillin formulation to existing safety and efficacy data.
How Vedic supported an FDA 505(b)(2) pathway by bridging a novel amoxicillin formulation to existing safety and efficacy data.
How Vedic supported an FDA 505(b)(2) pathway by bridging a novel amoxicillin formulation to existing safety and efficacy data.
How Vedic supported an FDA 505(b)(2) pathway by bridging a novel amoxicillin formulation to existing safety and efficacy data.
How Vedic supported an FDA 505(b)(2) pathway by bridging a novel amoxicillin formulation to existing safety and efficacy data.
How Vedic supported an FDA 505(b)(2) pathway by bridging a novel amoxicillin formulation to existing safety and efficacy data.
How Vedic applied sequential crossover rigor to clinically evaluate a TCM-inspired dermal patch.
How Vedic applied sequential crossover rigor to clinically evaluate a TCM-inspired dermal patch.
How Vedic applied sequential crossover rigor to clinically evaluate a TCM-inspired dermal patch.
How Vedic applied sequential crossover rigor to clinically evaluate a TCM-inspired dermal patch.
How Vedic applied sequential crossover rigor to clinically evaluate a TCM-inspired dermal patch.
How Vedic applied sequential crossover rigor to clinically evaluate a TCM-inspired dermal patch.
How Vedic delivered one of the largest probiotic RCTs to establish strain-specific efficacy in IBS.
How Vedic delivered one of the largest probiotic RCTs to establish strain-specific efficacy in IBS.
How Vedic delivered one of the largest probiotic RCTs to establish strain-specific efficacy in IBS.
How Vedic delivered one of the largest probiotic RCTs to establish strain-specific efficacy in IBS.
How Vedic delivered one of the largest probiotic RCTs to establish strain-specific efficacy in IBS.
How Vedic delivered one of the largest probiotic RCTs to establish strain-specific efficacy in IBS.
How patient-centric execution agility during a pandemic enabled the generation of publishable immune evidence under extreme real-world constraints.
How patient-centric execution agility during a pandemic enabled the generation of publishable immune evidence under extreme real-world constraints.
How patient-centric execution agility during a pandemic enabled the generation of publishable immune evidence under extreme real-world constraints.
How patient-centric execution agility during a pandemic enabled the generation of publishable immune evidence under extreme real-world constraints.
How patient-centric execution agility during a pandemic enabled the generation of publishable immune evidence under extreme real-world constraints.
How patient-centric execution agility during a pandemic enabled the generation of publishable immune evidence under extreme real-world constraints.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How Vedic built a full joint-health evidence portfolio from screening to dose-response and multi-indication claims.
How Vedic built a full joint-health evidence portfolio from screening to dose-response and multi-indication claims.
How Vedic built a full joint-health evidence portfolio from screening to dose-response and multi-indication claims.
How Vedic built a full joint-health evidence portfolio from screening to dose-response and multi-indication claims.
How Vedic built a full joint-health evidence portfolio from screening to dose-response and multi-indication claims.
How Vedic built a full joint-health evidence portfolio from screening to dose-response and multi-indication claims.
How Vedic proved vascular mechanism, not just symptom relief, in an early PAD population using hospital-grade microcirculation endpoints.
How Vedic proved vascular mechanism, not just symptom relief, in an early PAD population using hospital-grade microcirculation endpoints.
How Vedic proved vascular mechanism, not just symptom relief, in an early PAD population using hospital-grade microcirculation endpoints.
How Vedic proved vascular mechanism, not just symptom relief, in an early PAD population using hospital-grade microcirculation endpoints.
How Vedic proved vascular mechanism, not just symptom relief, in an early PAD population using hospital-grade microcirculation endpoints.
How Vedic proved vascular mechanism, not just symptom relief, in an early PAD population using hospital-grade microcirculation endpoints.
Categories
Categories
Categories
Therapeutic
Regulatory
Men's Health
Women's Health
Sports Nutrition
Metabolic Health
Joint Health
Heart Health
Gut Health
How Vedic executed an integrated mechanistic, pharmacokinetic, and safety program to support botanical drug development.
How biomarker-led trial design validated oxidative stress as a modifiable driver of obesity.
How cross-over design and acute metabolic kinetics enabled clean detection of thermogenic response.
How dose-comparison design and DXA-based body composition analytics separate fat loss from weight noise in obesity trials.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How signal-focused trial design separated true metabolic benefit from lifestyle-driven weight change.
How Vedic conducted FDA- and EMA-aligned pivotal RCTs to advance botanical drugs for type 2 diabetes.
How Vedic supported one of its earliest FSMP approvals by aligning nutrition-based diabetes trials to European regulatory expectations.
How Vedic enabled first-of-kind safety assessment for an allogeneic stem cell program in a regulatory grey zone.
Therapeutic
Regulatory
Men's Health
Sports Nutrition
Metabolic Health
Joint Health
Gut Health
How Vedic executed an integrated mechanistic, pharmacokinetic, and safety program to support botanical drug development.
How biomarker-led trial design validated oxidative stress as a modifiable driver of obesity.
How cross-over design and acute metabolic kinetics enabled clean detection of thermogenic response.
How dose-comparison design and DXA-based body composition analytics separate fat loss from weight noise in obesity trials.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How signal-focused trial design separated true metabolic benefit from lifestyle-driven weight change.
How Vedic conducted FDA- and EMA-aligned pivotal RCTs to advance botanical drugs for type 2 diabetes.
How Vedic supported one of its earliest FSMP approvals by aligning nutrition-based diabetes trials to European regulatory expectations.
How Vedic enabled first-of-kind safety assessment for an allogeneic stem cell program in a regulatory grey zone.
Therapeutic
Regulatory
Men's Health
Sports Nutrition
Metabolic Health
Joint Health
Gut Health
How Vedic executed an integrated mechanistic, pharmacokinetic, and safety program to support botanical drug development.
How biomarker-led trial design validated oxidative stress as a modifiable driver of obesity.
How cross-over design and acute metabolic kinetics enabled clean detection of thermogenic response.
How dose-comparison design and DXA-based body composition analytics separate fat loss from weight noise in obesity trials.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How signal-focused trial design separated true metabolic benefit from lifestyle-driven weight change.
How Vedic conducted FDA- and EMA-aligned pivotal RCTs to advance botanical drugs for type 2 diabetes.
How Vedic supported one of its earliest FSMP approvals by aligning nutrition-based diabetes trials to European regulatory expectations.
How Vedic enabled first-of-kind safety assessment for an allogeneic stem cell program in a regulatory grey zone.
Therapeutic
Regulatory
Men's Health
Women's Health
Sports Nutrition
Metabolic Health
Joint Health
Heart Health
Gut Health
How Vedic executed an integrated mechanistic, pharmacokinetic, and safety program to support botanical drug development.
How biomarker-led trial design validated oxidative stress as a modifiable driver of obesity.
How cross-over design and acute metabolic kinetics enabled clean detection of thermogenic response.
How dose-comparison design and DXA-based body composition analytics separate fat loss from weight noise in obesity trials.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How signal-focused trial design separated true metabolic benefit from lifestyle-driven weight change.
How Vedic conducted FDA- and EMA-aligned pivotal RCTs to advance botanical drugs for type 2 diabetes.
How Vedic supported one of its earliest FSMP approvals by aligning nutrition-based diabetes trials to European regulatory expectations.
How Vedic enabled first-of-kind safety assessment for an allogeneic stem cell program in a regulatory grey zone.
Therapeutic
Regulatory
Mechanism Evaluation
Men's Health
Women's Health
Sports Nutrition
Metabolic Health
Joint Health
Heart Health
Healthy Aging
Muscle Health
Gut Health
Weight Management
Toxicology
Immunity
How Vedic executed an integrated mechanistic, pharmacokinetic, and safety program to support botanical drug development.
How biomarker-led trial design validated oxidative stress as a modifiable driver of obesity.
How cross-over design and acute metabolic kinetics enabled clean detection of thermogenic response.
How dose-comparison design and DXA-based body composition analytics separate fat loss from weight noise in obesity trials.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How signal-focused trial design separated true metabolic benefit from lifestyle-driven weight change.
How Vedic conducted FDA- and EMA-aligned pivotal RCTs to advance botanical drugs for type 2 diabetes.
How Vedic supported one of its earliest FSMP approvals by aligning nutrition-based diabetes trials to European regulatory expectations.
How Vedic enabled first-of-kind safety assessment for an allogeneic stem cell program in a regulatory grey zone.
Therapeutic
Regulatory
Men's Health
Women's Health
Sports Nutrition
Metabolic Health
Joint Health
Heart Health
Gut Health
How Vedic executed an integrated mechanistic, pharmacokinetic, and safety program to support botanical drug development.
How biomarker-led trial design validated oxidative stress as a modifiable driver of obesity.
How cross-over design and acute metabolic kinetics enabled clean detection of thermogenic response.
How dose-comparison design and DXA-based body composition analytics separate fat loss from weight noise in obesity trials.
How multi-endpoint neuropathy assessment and early-onset response tracking enabled interpretable pain relief evidence in diabetes.
How signal-focused trial design separated true metabolic benefit from lifestyle-driven weight change.
How Vedic conducted FDA- and EMA-aligned pivotal RCTs to advance botanical drugs for type 2 diabetes.
How Vedic supported one of its earliest FSMP approvals by aligning nutrition-based diabetes trials to European regulatory expectations.
How Vedic enabled first-of-kind safety assessment for an allogeneic stem cell program in a regulatory grey zone.
Go Beyond The Abstract
Access Publications
Download
Go Beyond The Abstract
Access Publications
Download
Go Beyond The Abstract
Access Publications
Download
Go Beyond The Abstract
Access Publications
Download
Go Beyond The Abstract
Access Publications
Download
Go Beyond The Abstract
Access Publications
Download
What's Up At Vedic!
Explore Latest Edition
Download
What's Up At Vedic!
Explore Latest Edition
Download
What's Up At Vedic!
Explore Latest Edition
Download
What's Up At Vedic!
Explore Latest Edition
Download
What's Up At Vedic!
Explore Latest Edition
Download
What's Up At Vedic!
Explore Latest Edition
Download
Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
connect@vediclifesciences.com
203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053
Want to Join Vedic? Reach our HR
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis
Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
Want to Join Vedic? Reach our HR
connect@vediclifesciences.com
203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis
Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis
Want to Join Vedic? Reach our HR
connect@vediclifesciences.com
203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053
Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
connect@vediclifesciences.com
203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053
Want to Join Vedic? Reach our HR
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis
Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
connect@vediclifesciences.com
203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053
Want to Join Vedic? Reach our HR
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis
Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic lifesciences scoops Nutra
Ingredients research project award.
connect@vediclifesciences.com
203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053
Want to Join Vedic? Reach our HR
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis